|

iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes

RECRUITINGN/ASponsored by The University of Texas Health Science Center, Houston
Actively Recruiting
PhaseN/A
SponsorThe University of Texas Health Science Center, Houston
Started2019-11-12
Est. completion2021-11-12
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04206748

Summary

The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria

* All patients \>/= women 18 years of age with gestational diabetes or type 2 diabetes during pregnancy and identified by the research team and consented before 30.6 weeks.
* Non-anomalous singletons
* Ability to provide informed consent

Exclusion Criteria

* Patients with Type 1 diabetes
* Patients with fetal major congenital abnormalities
* Patients identified/referred after 30.6 weeks

Conditions4

DiabetesGestational DiabetesPregnancy in DiabeticType2 Diabetes

Locations1 site

The University of Texas Health Science Center at Houston
Houston, Texas, 77030
Joycelyn Cornthwaite, RD832-325-7205joycelyn.a.cornthwaite@uth.tmc.edu

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.